← FDA DRUG APPROVALS

FDA ANDA · ANDA216297

GLYCOPYRROLATE

Sponsor: SCIEGEN PHARMS

APPLICATION
ANDA216297
TYPE
ANDA
ORIGINAL APPROVAL
2024-10-07
LATEST ACTION
2025-06-13
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

GLYCOPYRROLATEPrescription
GLYCOPYRROLATE 1MG/5ML · SOLUTION · ORAL

Approval history

2025-06-13Labeling · Supplement 1 · standardAP
2024-10-07UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →